Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vivos Therapeutics develops and commercializes innovative diagnostic tools and non-invasive, proprietary oral appliances for treating obstructive sleep apnea (OSA) and related conditions. Its multidisciplinary approach, The Vivos Method, combines custom appliances, diagnostics, and therapy to expand airway space, offering a cost-effective alternative to CPAP and surgery. The company targets healthcare providers and patients worldwide, emphasizing clinical efficacy, regulatory approvals, and strategic alliances to grow its market share.
This description was generated via AI from an annual report. Updated about 1 year ago.